U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07067788) titled 'B.Brilliant Revelation Comparision Study' on May 12.
Brief Summary: This is an observational study to evaluate the MAMMOMAT B.brilliant system. All diagnostic decisions are made by the treating radiologist based upon standard of care clinical imaging acquired on FDA approved devices
Study Start Date: July 30
Study Type: OBSERVATIONAL
Condition:
Breast Cancer Screening
Intervention:
DIAGNOSTIC_TEST: Breast Imaging
Intervention using an FDA-approved mammogram machine.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Pennsylvania
Published by HT Digital Content Services with permission from Health Daily Digest....